Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 94.42%-32.88K | 28.69%-393.81K | 45.92%-714.45K | 38.31%-2.59M | 35.44%-130.15K | 38.02%-589.28K | 70.92%-552.24K | -14.74%-1.32M | -3,091.65%-4.2M | 28.93%-201.59K |
| Net income from continuing operations | -109.73%-507.17K | 49.67%-704.19K | 58.61%-622.78K | 115.08%1.35M | 67.47%-960.68K | 446.61%5.21M | 41.45%-1.4M | 28.11%-1.5M | -7.45%-8.94M | 51.42%-2.95M |
| Operating gains losses | 100.96%60.37K | -2,647.18%-253.18K | -1,058.23%-340.67K | ---6M | --346.98K | -10,059.09%-6.31M | -112.42%-9.22K | -174.70%-29.41K | ---- | ---- |
| Depreciation and amortization | -12.01%117.97K | -23.78%116.79K | -26.04%115.62K | -19.64%579.03K | -34.81%135.39K | -22.30%134.08K | -24.93%153.24K | 14.76%156.33K | 161.57%720.58K | 94.31%207.68K |
| Asset impairment expenditure | --0 | --0 | -79.10%2.18K | -76.14%317.85K | -90.60%110.11K | 169.84%170.79K | -72.80%26.54K | 1,344.24%10.41K | 48.83%1.33M | 55.69%1.17M |
| Remuneration paid in stock | -39.38%64.6K | 185.06%81.11K | 281.08%110K | 232.73%462.27K | 724.35%298.39K | 202.73%106.56K | -8.93%28.45K | -20.46%28.87K | -85.85%138.93K | -96.31%36.2K |
| Deferred tax | ---- | ---- | ---- | -5.31%-216.05K | ---- | ---- | ---- | ---- | ---205.16K | ---- |
| Other non cashItems | 142.44%159.83K | 837.70%336.73K | 54.70%-38.3K | -363.22%-279.41K | -59.98%145.78K | -24.29%-376.56K | 189.46%35.91K | -3.82%-84.54K | -102.79%-60.32K | --364.23K |
| Change In working capital | -84.91%71.53K | -65.20%213.01K | -222.30%-124.58K | -57.39%1.2M | -99.19%9.93K | -26.77%474K | 394.88%612.02K | -87.43%101.87K | -29.65%2.81M | -50.97%1.23M |
| -Change in receivables | 138.95%100.41K | -266.30%-79.25K | 411.19%191.4K | -695.84%-341.1K | -100.04%-167 | 21.88%-257.79K | -117.21%-21.63K | 80.45%-61.51K | -102.00%-42.86K | -29.59%475.96K |
| -Change in inventory | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 103.45%13.57K | --0 |
| -Change in prepaid assets | -52.98%12.62K | -192.28%-1.24K | -96.56%3.82K | 699.85%159.68K | 114.68%20.45K | -78.06%26.84K | -89.01%1.35K | 607.54%111.04K | -1,157.44%-26.62K | -433.93%-139.35K |
| -Change in payables and accrued expense | 36.63%300.11K | -38.17%293.5K | -1,612.83%-319.8K | 287.14%1.16M | 14.38%442.7K | 8,818.15%219.65K | 181.50%474.69K | -95.70%21.14K | 41.68%299.17K | -24.09%387.03K |
| -Change in other current assets | --0 | --0 | --0 | 73.65%-182.09K | 389.54%117.21K | 24.79%-116.71K | 70.44%-85.57K | 52.90%-97.02K | ---691.11K | ---40.48K |
| -Change in other working capital | ---- | ---- | ---- | -87.63%403.14K | -204.33%-570.26K | -40.26%602K | -71.64%243.18K | -84.86%128.21K | 59.69%3.26M | -69.64%546.61K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 94.42%-32.88K | 62.02%-209.74K | 31.98%-898.53K | 38.31%-2.59M | 35.44%-130.15K | 38.02%-589.28K | 70.92%-552.24K | -14.74%-1.32M | -3,091.65%-4.2M | 28.93%-201.59K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 754.10%359.56K | 114.10%46.77K | 97.34%-8.67K | -137.60%-16.77K | 588.08%30.11K | 194.32%42.1K | -119.21%-331.64K | -114.55%-325.44K |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 98.01%-8.46K | 53.31%-3.67K |
| Net intangibles purchas and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 69.83%-330.96K | ---- |
| Net business purchase and sale | --0 | --0 | --359.56K | ---27.73K | --0 | ---27.73K | --0 | --0 | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | 857.58%74.5K | -194.26%-8.67K | -77.29%10.96K | 588.08%30.11K | 196.75%42.1K | -99.76%7.78K | -99.70%9.19K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 754.10%359.56K | 114.10%46.77K | 97.34%-8.67K | -137.60%-16.77K | 588.08%30.11K | 194.32%42.1K | -119.21%-331.64K | -114.55%-325.44K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -81.24%117.32K | -86.80%48.95K | -10.42%636.76K | 392.49%1.77M | 141.98%58.04K | 505.55%625.52K | 561.98%370.95K | 408.02%710.85K | -7.90%-603.56K | -127.50%-138.24K |
| Net issuance payments of debt | 664.83%118.14K | -87.05%49.52K | 125.99%97.95K | 107.11%37.49K | 141.72%52.99K | 84.82%-20.92K | 780.66%382.33K | -82.35%-376.91K | -42.82%-527.65K | -122.36%-126.99K |
| Net common stock issuance | --0 | --0 | -50.95%539.53K | --1.76M | --7.57K | --654.07K | --0 | --1.1M | --0 | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | 89.35%-813 | 95.05%-563 | 94.11%-721 | 55.51%-33.77K | 77.66%-2.51K | 53.60%-7.63K | 52.81%-11.38K | 49.17%-12.24K | 1.03%-75.91K | 59.72%-11.25K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -81.24%117.32K | -86.80%48.95K | -10.42%636.76K | 392.49%1.77M | 141.98%58.04K | 505.55%625.52K | 561.98%370.95K | 408.02%710.85K | -7.90%-603.56K | -127.50%-138.25K |
| Net cash flow | ||||||||||
| Beginning cash position | -89.61%20.13K | -32.39%231.55K | -91.59%77.12K | -84.73%916.7K | -87.82%186.46K | -92.52%193.85K | -92.52%342.5K | -84.73%916.7K | 20.83%6M | -56.86%1.53M |
| Current changes in cash | 333.59%84.44K | -6.34%-160.78K | 117.21%97.79K | 84.81%-780.6K | 87.86%-80.78K | 101.84%19.47K | 92.39%-151.19K | 60.18%-568.11K | -596.42%-5.14M | -127.10%-665.27K |
| Effect of exchange rate changes | 206.73%28.67K | -2,094.33%-50.64K | 1,028.47%56.65K | -215.47%-58.99K | -155.91%-28.56K | ---26.86K | --2.54K | ---6.1K | --51.08K | --51.08K |
| End cash Position | -28.54%133.24K | -89.61%20.13K | -32.39%231.55K | -91.59%77.12K | -91.59%77.12K | -87.82%186.46K | -92.52%193.85K | -92.52%342.5K | -84.73%916.7K | -84.73%916.7K |
| Free cash from | 94.42%-32.88K | 62.02%-209.74K | 31.98%-898.53K | 42.92%-2.59M | 75.73%-130.15K | 38.26%-589.28K | 70.92%-552.24K | -14.62%-1.32M | -174.72%-4.54M | 61.38%-536.22K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.